Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old
Clinical trial NCT05015686 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05015686
- Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2022-02-09
- Enrollment
- 2400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.